Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,318.00    256.00 (1.82%)
Bid:
14,256.00
Ask:
14,262.00
Spread: 6.00 (0.042%)
Market Cap: £222.05b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

LONDON BRIEFING: Lloyds Banking Group ups motor finance provision
13 Oct 2025

LONDON BRIEFING: Lloyds Banking Group ups motor finance provision

(Alliance News) - Lender Lloyds Banking Group has set aside another GBP800 million related to motor finance matters, Oxford Instruments reports a tari...

Trump announces deal with AstraZeneca on drug prices, tariffs
13 Oct 2025

Trump announces deal with AstraZeneca on drug prices, tariffs

(Alliance News) - US President Donald Trump announced a deal with AstraZeneca PLC on Friday that he said would lead to significantly lower domestic dr...

AstraZeneca to cut US drug prices in key White House deal
13 Oct 2025

AstraZeneca to cut US drug prices in key White House deal

(Sharecast News) - AstraZeneca has struck a deal with the White House to cut drugs prices in America, allowing it to avoid steep tariffs on US imports...

PRESS: Trump strikes drug-pricing deal with AstraZeneca - MSNBC
10 Oct 2025

PRESS: Trump strikes drug-pricing deal with AstraZeneca - MSNBC

(Alliance News) - President Donald Trump on Friday plans to announce an agreement with the pharmaceuticals firm AstraZeneca PLC to lower drug prices i...

AstraZeneca ups investment at new Virginia facility to USD4.5 billion
9 Oct 2025

AstraZeneca ups investment at new Virginia facility to USD4.5 billion

(Alliance News) - AstraZeneca PLC on Thursday said it will increase investment at its new Virginia manufacturing facility by USD500 million, bringing ...

AstraZeneca touts positive results in trial for hypertension therapy
7 Oct 2025

AstraZeneca touts positive results in trial for hypertension therapy

(Alliance News) - AstraZeneca PLC on Tuesday said its therapy for hypertension demonstrated positive results in a recent phase 3 trial, while its brea...

AstraZeneca's Baxdrostat hits Phase III endpoint in resistant hypertension
7 Oct 2025

AstraZeneca's Baxdrostat hits Phase III endpoint in resistant hypertension

(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that Baxdrostat had met its primary endpoint in the Bax24 Phase III trial, delivering a "stat...

LONDON MARKET MIDDAY: UK construction confidence remains weak
6 Oct 2025

LONDON MARKET MIDDAY: UK construction confidence remains weak

(Alliance News) - Stock prices in London were mostly lower at midday on Monday, while data published by S&P Global showed that the UK construction sec...